UK-based healthtech firm Semble has secured $15m in Series B funding, led by Mercia Ventures with participation from Octopus Ventures, Smedvig Ventures, and Triple Point. The investment aims to bolster Semble’s UK presence and fund its recent launch in France. Semble’s platform, designed to reduce healthcare providers’ administrative load, integrates with third-party systems and leverages…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2025 All rights reserved LaingBuisson 
